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Moderate physical exercise is associated with an irrefutable reduction in cardiac morbidity and mortality. The current guidelines recom-
mend at least 150 min of moderate exercise or 75 min of vigorous exercise per week. Endurance athletes perform exercise at a level that
is 10- to 20-fold greater than these recommendations. These athletes reveal several structural and functional cardiac adaptations including
increased cardiac size, enhanced ventricular filling, and augmentation of stroke volume even at the highest heart rates. The long-term
effects of endurance exercise on the heart are unknown. Endurance exercise is associated with a transient increase in serum concentra-
tions of biomarkers of cardiac damage and ventricular dysfunction which improves within 72 h. Over the past decade, there have been
emerging studies reporting attenuated mortality benefit amongst individuals who perform the highest volume of exercise. Studies in life-
long male athletes aged above 40 years old show a higher prevalence of high coronary artery calcium scores (>300 Agatston units), a
higher coronary plaque burden, and myocardial fibrosis compatible with subclinical myocardial infarction compared with relatively seden-
tary healthy controls, raising speculation that lifelong intense exercise imposes chronic coronary stress on the heart. This review article
will provide a critical analysis of the existing data.
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The benefits of exercise
The benefits of regular physical exercise on the human body are mul-
tiple and indisputable. The improvements in cardiovascular risk pro-
file associated with exercise are partly secondary to its positive
impact on atherosclerotic risk factors such as blood pressure, lipid
profile, body mass index, and insulin resistance.1 Although intensive
exercise acutely has a pro-inflammatory effect that potentially
increases the risk of coronary inflammation, atherosclerotic plaque
destabilization, and rupture, regular exercise generally exerts an anti-
inflammatory effect on the vascular endothelium and triggers myo-
kine release from skeletal muscle. Exercise promotes nitric oxide
production from the vascular endothelium, thus improving vasodila-
tory capacity, vascular homeostasis, and deactivation of scavenging
oxidative species.2,3 Exercise also stimulates angiogenesis, which
increases tissue oxygen transport and inhibits cell adhesion molecules
that otherwise mediate the inflammatory atherosclerotic process.4
According to animal studies, the protective effect of exercise on the
endothelium is dose-dependent and varies depending on exercise
protocol and vessels.2 There is currently no evidence suggesting any
one exercise type has a preferential benefit on endothelial function
over another. As with most beneficial effects of exercise, optimal
endothelial function is achieved through regular moderate-intensity
physical exercise. Extreme strenuous and exhaustive exercise con-
trarily increase oxidative stress and can result in a systemic inflamma-
tory response, although this is usually short-lived and resolves within
a few hours.4,5
Current physical activity guidelines recommend a minimum of
30 min of moderate physical activity per day 5 days per week or
25 min of vigorous activity per day, 3 days per week6; however, indi-
viduals engaging in endurance sports exercise at levels far beyond
these recommendations. In the past decade, there have been several
reports of a reverse J-shaped dose–response relationship between
lifetime exercise exposure and cardiovascular morbidity, suggesting
there is a threshold beyond which some of the aforementioned bene-
fits of exercise are lost.7,8 These studies have led to an ongoing de-
bate regarding the potential deleterious effect of a cumulative dose of
high-intensity endurance training on the heart.
Graphical Abstract
Life-long middle-aged male 1 endurance athletes demonstrate increased prevalence of high coronary calcium scores. Contributing factors include genetic
predisposition, ageing and the prevalence or recognised atherosclerotic risk factors. Additionally, exercise is associated with mechanical flexing of the
arteries, coronary inflammation and a hypertensive response to exercise. Some athletes may develop ischaemic scar and increased risk of ventricular
arrhythmias, however longitudinal studies are necessary to investigate this further. BP, blood pressure; IL1, interleukin-1; PTH, parathyroid hormone;
TNFa, tumour necrosis factor alpha.
....................................................................................................................................................................................................































































































Ageing, exercise, and the
cardiovascular system
The cardiovascular system undergoes a plethora of age-related struc-
tural and functional changes that impact on cardiac reserve. At a cellu-
lar level, there is a gradual decline in the number of myocytes and a
compensatory increase in myocyte size, resulting in mild left ventricu-
lar (LV) hypertrophy.9,10 Functionally, there is an overall reduction in
cardiac energetics, specifically, prolongation of relaxation time causing
increased preload, an increase in vascular and myocardial stiffness, and
loss of catecholamine sensitivity causing an increased afterload.11
These changes result in a reduced LV end-systolic volume and
reduced ejection fraction reserve.10 The long-term physiological
effects of exercise training attenuate some of these age-related
changes through its anti-inflammatory and anti-oxidative effects.
Exercise slows the rate of arterial stiffening and prevents the develop-
ment of vascular disease,12 offsets age-related reductions in LV compli-
ance and distensibility and attenuates the rate of fall in maximum
oxygen consumption.13,14 However, exercise does not appear to slow
the age-related reduction in maximum heart rate from reduced beta-
adrenergic responsivity and intrinsic slowing of the sinoatrial node.10
Ageing and skeletal muscle
Sarcopenia, the loss of muscle mass with ageing, results from the re-
placement of type II ‘fast-twitch’ muscle fibres and motor units with fat
and connective tissue, causing loss of contractile and metabolic myo-
cyte function.15 Driving factors for sarcopenia include chronic low-
grade inflammation, oxidative stress, impaired regenerative capacity,
and impaired protein synthesis—despite feeding and exercise.16 Onset
is usually in the 5th decade but only usually becomes evident in the 7th
decade and explains why athletic performance deteriorates with age, in
particular, explosive forms of exercise. Due to the more gradual decline
in ‘slow-twitch’ fibres, individuals can continue to compete in endurance
sports at elite level into the 5th and 6th decades. A retrospective ana-
lysis of 43 551 participants in ultra-marathons worldwide demonstrated
the mean age of the top 10 ranked athletes was 43.4-years and 42.1-
years in females and males, respectively. There was no deterioration in
peak running times in athletes until they reached the 6th decade.17
Cardiovascular adaptation to
exercise
Endurance athletes impose huge demands on the cardiovascular sys-
tem and manifest the most profound physiological cardiovascular
adaptations to exercise. The constellation of adaptations often
referred to as the ‘athlete’s heart’ are well-defined in young athletes.
These include profound sinus bradycardia, increased QRS voltages,
cardiac chamber dilatation and increased LV wall thickness, enhanced
diastolic ventricular filling, and high peak oxygen consumption.18
In addition, athletes demonstrate an increase in pulmonary artery
diameter; however, pulmonary vascular resistance remains un-
changed in most athletes.19 The magnitude of such adaptation varies
according to age, sex, ethnicity, sporting discipline, and intensity of
exercise. In general, adult male endurance athletes with a body sur-
face area >_2 m2 reveal the largest cardiac dimensions.
Cardiac adaptation in the master athlete
Cardiovascular adaptation to exercise in master athletes is less well-
defined and more complex due to the interplay between training
effects, ageing, and the cumulative impact of lifestyle-related cardio-
vascular risk factors. Despite this complex interaction, master ath-
letes adapt similarly to their younger counterparts by increasing
cardiac dimensions and mass.20,21 Merghani et al.22 demonstrated an
up to 15% greater end-diastolic volume and 9.9% greater maximal
wall thickness in master endurance athletes compared with non-
athletic controls. Compared with young athletes, master athletes
demonstrate increased LV wall thickness and left atrial size, but less
extensive chamber dilatation. From a functional perspective, LV ejec-
tion fraction is unchanged; however, stroke volume is increased as
are indices of diastolic function.22
Sudden cardiac death in master
athletes
Sudden death during sport effects1 in 50 000 individuals. Over 90%
of all exercise-related sudden cardiac deaths (SCDs) occurs in the
middle-aged and older population.23 Coronary atherosclerosis is the
most common cause of SCD in master athletes accounting for more
than 80% of deaths24 with a high male preponderance in both com-
petitive and recreational sports.25,26 The acute effects of exercise in-
crease the predilection for plaque rupture and resultant myocardial
infarction by up to 10-fold.25,27 The risk of acute myocardial infarction
and SCD is inversely related to the amount of habitual exercise per-
formed.27 Individuals exercising up to five times per week have a 50-
fold lower risk of myocardial infarction and a 7-fold lower risk of SCD
compared with individuals who exercise infrequently.28 Commonly
proposed mechanisms for myocardial infarction during exercise in-
clude a combination of endothelial erosion resulting in plaque rupture,
neuro-hormonal activation, and hypercoagulability.26 However, pla-
que rupture is not the only mechanism by which atherosclerosis exac-
erbates sudden death during extreme exercise. In a case series of
SCD during marathons in the USA, there was no evidence of throm-
bus or plaque rupture.29 Alternative mechanistic possibilities include
demand ischaemia from obstructive coronary artery stenosis and cor-
onary vasospasm from increased sympathetic activity.30 Other causes
of exercise-related SCD in master athletes include the cardiomyopa-
thies, myocarditis, valvular heart disease, and aortic rupture.24
Can exercise damage an
otherwise healthy heart?
Endurance sporting events are associated with a transient rise in
serum biomarkers of myocardial damage including troponin and brain
natriuretic peptide (BNP); temporary right, and to a lesser extent, LV
systolic dysfunction, and impaired myocardial relaxation. The signifi-
cance of transient rises in biomarkers is unclear. The transient rise
and normalization of serum cardiac troponin concentrations within
48 h suggest that the troponin originates from the cytosol rather than
























































..the sarcomere and enters the circulation due to increased myocyte
membrane permeability. Episodes of acutely raised serum troponin
may represent myocyte necrosis from subtle myocardial inflamma-
tion or microinfarction, such that repeated events could culminate in
adverse cardiac remodelling and arrhythmias.31,32 Abnormal levels of
BNP following an endurance event have been associated with right
ventricular dysfunction and possibly represent prolonged and
repeated wall stress due to a raised cardiac output. A small propor-
tion of ostensibly healthy master athletes reveal atrial fibrillation, cor-
onary artery calcification, and myocardial fibrosis,33 which has
increased speculation about the potentially deleterious impact of
chronic endurance exercise on cardiovascular health.
Middle-aged endurance athletes are at a five-fold increased risk of
atrial fibrillation compared with sedentary counterparts. Proposed
mechanisms include shortening of the atrial action potential due to
increased vagal tone, and direct effects on the atrial myocardium,
including mechanical stretch, inflammation, and fibrosis. Extrinsic con-
tributing factors include male sex, tall stature, and the volume and in-
tensity of exercise.34
Coronary artery disease in master
athletes
The coronary artery calcium (CAC) score, as measured by computed
tomography (CT), is a surrogate for atherosclerotic volume and a
strong predictor of future adverse cardiac events in the general popu-
lation.35,36 The CAC score is also used for risk stratification and inten-
sifying therapy for recognized atherosclerotic risk factors. Although
exercise is thought to be protective for coronary artery disease, there
is mounting evidence that male master athletes have higher CAC
scores and a greater prevalence of coronary atherosclerosis on
coronary CT angiography (CCTA), compared with age and athero-
sclerotic risk-matched controls.22,37 Möhlenkamp and colleagues37
investigated CAC in 108 ostensibly healthy males aged 50–72 years
who had run >_5 marathons and compared them with 864 age-
matched controls. The prevalence of a CAC score >_100 Agatston
units (AU) was similar in both groups (36%). After matching for
Framingham score, CAC score was higher in marathon runners than
controls (36% vs. 12%). The Measuring Athlete’s Risk of
Cardiovascular Events (MARC) study demonstrated amongst 318
middle-aged male endurance athletes (mean age 54.7-years), who
could exercise to high workloads (318 ± 48 Watts), and of whom 94%
had a low ESC 10-year risk score, that 16% had a CAC score
>_100 AU.38
Our group recruited 152 master endurance athletes with a low
Framingham risk score and 92 age and Framingham risk-matched
controls. Athletes had a mean age of 51 years, a mean Framingham
risk score of 4.33% and had been competing in endurance sports for
a mean of 31 years. All participants underwent comprehensive testing
including CCTA and CAC score. There was no difference in the
prevalence of a CAC score of zero or a CAC score >70th percentile
between the two groups; however, almost one in five male athletes
had a CAC score >_100 AU and 11.3% demonstrated a CAC score
>300 AU compared with none of the male controls. Male athletes
had a significantly greater proportion of calcific plaques, which are
considered stable and less prone to rupture, compared with controls
(72% vs. 31%; P = 0.0002). Controls had a significantly higher preva-
lence of mixed morphology plaque, which is more vulnerable to rup-
ture resulting in acute coronary thrombosis22 (Figure 1).
There are currently no studies amongst athletes examining
markers of plaque vulnerability such as peri-coronary adipose tissue
or CT markers such as spotty calcification, napkin ring sign, and posi-
tive remodelling. Such data could provide valuable insight into
Figure 1 (A) Coronary computed tomography angiography demonstrating mixed morphology plaque in the proximal left anterior descending ar-
tery in a male master athlete. (B) Breakdown of coronary plaques according to morphology in male athletes and controls. Athletes have a higher
prevalence of calcified plaques compared with controls.22























































characterizing and quantifying the risk of coronary lesions and their
relationship to other potentially related structural changes such as
myocardial fibrosis, in athletes. One study of consecutive patients
referred for CCTA demonstrated a lower prevalence of non-
calcified plaque and high-risk markers amongst those regularly endur-
ance training.39 A further study of patients with angina undergoing
percutaneous coronary intervention used intravascular ultrasound,
optimal coherence tomography, and cardiopulmonary exercise test-
ing to demonstrate a smaller lipid volume, greater fibrous volume,
and thicker fibrous cap in those with greater cardiorespiratory
fitness (CRF).40
Association between intense exercise
and coronary atherosclerosis
The MARC study investigators used their data to evaluate the rela-
tionship between coronary atherosclerosis and exercise dose (MET-
min/week) in 284 men. Athletes were categorized as exercising for
<1000, 1000–2000, or >2000 MET-min/week. Those athletes with
the highest exercise dose had significantly greater CAC and more
atherosclerotic plaques. There was no relationship between exercise
dose and plaque morphology for mixed or non-calcified plaques;
however, athletes who exercised the most had the highest preva-
lence of calcified plaques41 (Figure 2 and Supplementary material on-
line, Table S1).
Mechanisms for coronary atherosclerosis
and coronary artery calcium in master
athletes
There are several proposed mechanisms underlying the develop-
ment of atherosclerotic coronary artery disease in male master
athletes. These include prolonged and repetitive mechanical stress
from flexing of the epicardial coronary arteries during vigorous car-
diac contraction, an excessively high blood pressure during exer-
cise,22,37,42 increased parathyroid hormone levels secondary to
exercise, and the acute pro-inflammatory state associated with
repeated prolonged bouts of intense exercise.43 Some athletes with
increased CAC have a genetic predisposition or established risk fac-
tors for atherosclerosis.
The greater prevalence of calcified rather than mixed morphology
plaques in male master athletes is also unexplained; however, differ-
ent endothelial repair mechanisms may be in place compared with
individuals with a high burden of atherosclerotic risk factors. It is pos-
sible that chronic endurance exercise accelerates calcification and
stabilizes plaques akin to the protective effect of high-dose sta-
tins.44,45 Interval scanning of 1255 disease-free patients in the
PARADIGM study revealed that statins resulted in slower progres-
sion of atherosclerosis, modestly lower overall plaque volume, lower
fibrous plaque volume, and an increase in dense calcium volume—a
marker of plaque stability.45 The mechanisms for these effects are
poorly understood; the anti-inflammatory properties of statins, as
with exercise, being one possibility.
Current studies suggest that the presence of CAC does not confer
the same level of risk amongst individuals engaging in large volumes of
intensive exercise as in the general population. Radford et al.46 eval-
uated the association between CRF, CAC score, and cardiovascular
events over an 8.4-year follow-up period in a cohort of 8425 men.
The study showed that a greater CRF reduced cardiovascular disease
events and a higher calcium score increased them. When considered
together, a greater continuous CRF attenuated the risk of cardiovas-
cular disease events when adjusted for CAC score. For each MET
Figure 2 Data from the Measuring Athlete’s Risk of Cardiovascular Events study demonstrating the relationship between exercise dose and coron-
ary artery calcium (CAC) (A) and prevalence of calcified plaques (B).41































































































increase in CRF across all CAC scores adjusted for risk factors, the
event rate was reduced by 14%. DeFina and colleagues47 demon-
strated that the most active individuals (>_3000 MET-min/week) had
an 11% greater relative risk of a CAC score >_100 AU compared with
less active controls. Despite having more calcium, athletes exercising
>3000 MET-min/week had no increase in mortality compared with
individuals performing 1500–3000 and <1500 MET-min/week.
There are a number of potential explanations for the failure to
demonstrate an increase in adverse outcomes in athletes with CAC.
Lifelong endurance athletes develop an array of protective cardiovas-
cular adaptations that result in significant coronary flow reserve.
These include ischaemic pre-conditioning, coronary collateralization,
and optimal vasodilatory capacity due to enhanced nitrous oxide pro-
duction. In the general population, the CAC score is a reflection of
overall atherosclerotic burden, therefore, we speculate that if exer-
cise increases the extent and density of endothelial calcification, the
overall atherosclerotic burden will be overestimated in athletes.
Should this be the case, the use of the CAC score as a surrogate
marker for quantifying coronary atherosclerotic volume, and there-
fore predicting cardiovascular morbidity and mortality risk, may not
be as valid in athletes as in the general population. An alternative hy-
pothesis is that CAC detected with CT occurs within the medial layer
of the artery wall as part of the healing process following smooth
muscle apoptosis, as opposed to the intimal layer—which is the site
of rupture-prone atherosclerosis. There are currently no in vivo
methods to differentiate these entities.
Sex differences in coronary artery
calcification in master athletes
Knowledge of the pattern of coronary atherosclerosis specifically in
the female master athlete is scant. A study of 26 lifelong female mara-
thon runners, having run at least one marathon per year for
10–25 years, showed a lower calcium burden and less plaques com-
pared with controls; however, the athletes also had a lower athero-
sclerotic risk factor profile. Athletes with plaques tended to be older
and were amongst those who had been running marathons for the
most years.48 Our own experience of 46 female athletes showed
that there was no difference in CAC score or prevalence of plaque
morphology compared with 38 age- and Framingham risk-matched
controls.22 These, albeit small studies, suggest that female athletes
may benefit from the protective effect of oestrogens pre-
menopause; however, the impact of the menopause on the preva-
lence of CAC in female athletes is unknown.
Endurance exercise and
sub-clinical infarction
Focal fibrosis affecting the right ventricular insertion points has been
observed in >40% of male master athletes and >30% of female mas-
ter athletes and considered a benign consequence of sustained re-
petitive right ventricular pressure and volume overload, with similar
findings in pulmonary hypertension.49 Major myocardial fibrosis
affecting the subendocardial layer, mid-wall, or subepicardial region
has been reported in 11–17% of master athletes and is confined to
males. The aetiology and mechanism for myocardial fibrosis are
unclear; however, a subendocardial pattern is suggestive of ischaemic
injury and a subepicardial pattern is compatible with a post-
inflammatory response. In our experience of 152 master endurance
athletes and 92 controls, 11% of master athletes revealed myocardial
fibrosis compared with no controls. Of these, one-third revealed fi-
brosis compatible with previous myocardial infarction, the remaining
two-thirds revealed a non-ischaemic scar pattern with a mid-wall or a
subepicardial distribution, most often characteristic of acute or
healed myocarditis,22 although a cardiomyopathic process acquired
through lifelong intensive exercise also merits consideration. Of the
athletes with scar compatible with myocardial infarction, only half
had a coronary stenosis in the relevant coronary artery and in each
case, the stenosis was <_50%. Möhlenkamp et al.37 showed that a
higher CAC percentile, in addition to number of marathons com-
pleted, was predictive for the presence of late gadolinium enhance-
ment (LGE). These results suggest that subendocardial fibrosis in
master athletes may represent sub-clinical myocardial infarction from
demand ischaemia, micro-emboli, and coronary spasm. The preva-
lence of coronary events at 6-year follow-up was 57% amongst those
with LGE vs. 8% in those without50 suggesting the presence of
LGE in addition to coronary calcification increases the risk of
adverse outcomes.
Myocardial fibrosis is an important finding due to its association
with ventricular arrhythmias and increased mortality in the general
population.51 Studies to date have not demonstrated a greater preva-
lence of ventricular arrhythmias in master athletes compared with
controls52 nor any direct association between myocardial fibrosis,
ventricular arrhythmias, and adverse events in master athletes.37 Our
relatively limited experience of arrhythmias in master athletes with
an ischaemic pattern of fibrosis revealed a higher prevalence of non-
sustained ventricular tachycardia than those without fibrosis (43% vs.
7%) with all three athletes with ventricular tachycardia revealing
a >_50% stenosis in the left anterior descending artery.22 Further
large-scale longitudinal studies are required to investigate the precise
impact of myocardial scar in athletes.
Conclusion
Regular physical exercise is imperative for the maintenance of opti-
mal health and longevity and should be globally encouraged. There is
emerging evidence that a proportion of athletes show high CAC
scores, a higher plaque burden and myocardial fibrosis compared
with age- and Framingham-matched controls. The mechanism and
significance of these findings are unclear. Current limited data find no
association between a high CAC score and all-cause mortality in
master athletes.
Future directions
Large prospective longitudinal studies in male master athletes are
required to investigate the cause and significance of CAC, coronary
plaques, and myocardial fibrosis in athletes. The potential major role
of inflammation in these findings merits further exploration. Further
characterization of the female veteran athlete’s heart, understanding
the impact of the menopause, and explaining the physiological































































































differences between females and males will greatly expand our cur-
rent understanding of the impact of exercise on the older athlete’s
heart.
Supplementary material
Supplementary material is available at European Heart Journal online.
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